Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1158 | 1043 | 1330 | 1324 | 1905 | 2805 |
Fund Return | 15.81% | 4.28% | 33.04% | 9.8% | 13.76% | 10.86% |
Place in category | 63 | 17 | 36 | 17 | 7 | 9 |
% in Category | 41 | 15 | 22 | 13 | 8 | 9 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
AXA 500 Managed Volatility Portfoli | 8.38B | 20.35 | 7.90 | 11.96 | ||
EQ/Equity 500 Index Portfolio Clasb | 7.04B | 19.07 | 8.78 | 12.32 | ||
AXA Aggressive Strategy Portfolio C | 5.76B | 12.53 | 3.26 | 7.66 | ||
AXA Growth Strategy Fund Class IB | 4.93B | 11.13 | 2.64 | 6.79 | ||
AXA Large Cap Growth Managed Vol IB | 4.81B | 21.95 | 6.18 | 13.71 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Dodge & Cox Stock | 68B | 15.98 | 8.60 | 11.25 | ||
Vanguard Equity-Income Adm | 53.42B | 15.14 | 8.73 | 10.28 | ||
Vanguard Windsor II Admiral | 49.3B | 14.13 | 7.13 | 10.64 | ||
American Funds American Mutual A | 42.64B | 16.17 | 8.16 | 9.70 | ||
Vanguard Value Index Adm | 38.02B | 17.31 | 9.16 | 10.42 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Exxon Mobil | US30231G1022 | 2.80 | 117.97 | -1.67% | |
Berkshire Hathaway B | US0846707026 | 2.74 | 478.56 | +0.24% | |
Wells Fargo&Co | US9497461015 | 2.36 | 77.35 | +0.59% | |
AbbVie | US00287Y1091 | 2.27 | 181.14 | +2.30% | |
CVS Health Corp | US1266501006 | 2.22 | 59.01 | -1.78% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review